Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Tuesday, February 9, 2010, 11:29pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
Pressure BioSciences, Inc. (PBIO)
At 15:40 EST:
1.79 USD
0.15 (8.91%)
MORE ON PBIO
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
Pressure BioSciences, Inc.
(NCM:PBIO) Delayed quote data
Last Trade:
1.79 USD
Trade Time:
3:40PM EST
Change:
0.15 (8.91%)
Prev Close:
1.64
Open:
1.51
Bid:
1.53
x 500
Ask:
2.79
x 100
1y Target Est:
2.50
Day's Range:
1.50 - 1.80
52wk Range:
0.55 - 2.10
Volume:
20,648
Avg Vol
(3m)
:
5,969.84
Market Cap:
3.93M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-1.25
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add PBIO to Portfolio
Download Data
HEADLINES
MoneyTV With Donald Baillargeon, 11/25
Marketwire
(Wed, Nov 25)
PRESSURE BIOSCIENCES INC Financials
EDGAR Online Financials
(Sat, Nov 21)
PRESSURE BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity
EDGAR Online
(Thu, Nov 19)
Chromcraft, pSivida: Midday Volume Plays
at TheStreet.com
(Wed, Nov 18)
PRESSURE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online
(Mon, Nov 16)
Q3 2009 Pressure BioSciences Earnings Release - Time Not Supplied
CCBN
(Mon, Nov 16)
Q3 2009 Pressure BioSciences Earnings Release - Time Not Supplied
CCBN
(Fri, Nov 13)
PRESSURE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
EDGAR Online
(Thu, Sep 17)
PRESSURE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online
(Mon, Aug 10)
PRESSURE BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online
(Fri, May 15)
More Headlines for PBIO...
ANALYST
EPS Est (next year)
(Dec-09)
:
-1.20
EPS Est (in 2 years)
(Dec-10)
:
-1.30
Avg Rec (current)*:
2.0
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Pressure BioSciences, Inc. (PBI) focuses on the development and commercialization of a novel, enabling technology called Pressure Cycling Technology (PCT).
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices